K150617

Substantially Equivalent

cobas HSV 1 and 2 Test

Applicant: Roche Molecular Systems, Inc.
Product code: OQO
Advisory panel: Microbiology
Date received: 2015-03-10
Decision date: 2015-06-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Pleasanton, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.